TABLE 2

Other Diagnoses and Medications Administered for Each Subject on the First Day of Pulmonary Embolism Presentation

SubjectOther Diagnoses and/or Recent Procedures NotedMedications AdministeredESR Level,a mm/hCRP Level,b mg/dLD-Dimer Level,c ng/mL
1Other venous embolism and thrombosisHeparin
2Overweight and obesity (BMI >40); asthmaEnoxaparin612.71.3
3None notedApixaban0.94
4Adverse effect of other estrogens and progestogens, initial encounterHeparin and enoxaparin
5Type 2 diabetes mellitus; overweight and obesity (BMI >40); and obstructive sleep apneaEnoxaparin and hydrocortisone
6Essential hypertension; other venous embolism and thrombosis; Wegener’s granulomatosis with renal involvement; and acute kidney failure; renal biopsyHeparin
7Elevated ESR; severe sepsis with shock; and encephalopathy, unspecifiedImmunoglobulin G, methylprednisolone, and enoxaparin37281
8Malignant neoplasm of long bones of left lower limb; acute myocardial infarction; cardiomyopathy; heart failure; intracardiac thrombosis, not elsewhere classified; acquired absence of left leg below knee; acute kidney failure; ascites; solitary pulmonary nodule; and laparoscopyEnoxaparin and aspirind
  • CRP, C-reactive protein; —, not applicable.

  • a ESR reference range, 0 to 15 mm/h.

  • b C-reactive protein reference range, <1 mg/dL.

  • c D-dimer reference range, ≤0.54 ng/mL.

  • d These medications were reported to be administered 14 d after a pulmonary embolism diagnosis was reported.